.png)
.jpg)
BLOG
Welcome
Progress is not how we grow; it is about how we make a difference in lives of others. This is our guiding principle at Yashraj Biotechnology Limited (YBL)
NAMs: A Human-Predictive Biological Architecture
NAMs should not be viewed simply as alternatives to animal testing. They represent a broader scientific architecture designed to improve predictive toxicology, human biological relevance, mechanistic understanding, translational confidence, and regulatory decision-making.
Predictive Toxicology
Generate earlier insights into safety liabilities and toxicological risks.
Human Biological Relevance
Build experimental systems that better replicate clinical biology.
Mechanistic Understanding
Reveal underlying pathways, biomarkers, and biological interactions.
Translational Confidence
Reduce uncertainty between preclinical observations and clinical outcomes.
Regulatory Decision-Making
Support evidence generation aligned with evolving regulatory expectations.
The FDA Broadly Defines NAMs To Include
Importantly, regulators increasingly evaluate NAM-generated evidence within a weight-of-evidence framework rather than rigid one-to-one replacement models. This marks a significant shift in how preclinical evidence is generated and assessed.
Defining the NAMs Toolkit
Modern NAMs function as interconnected scientific systems rather than isolated testing methods.
Human-Derived Cellular Platforms
Human relevant systems designed to improve biological predictability.
Computational Toxicology
Advanced models for toxicity prediction and risk assessment.
AI-Driven Prediction
Machine learning systems supporting compound evaluation.
Pharmacokinetic Modeling
Predictive exposure and absorption simulations.
Advanced Biochemical Characterization
High-quality biological analysis supporting translational confidence.
Rather than acting as isolated testing methods, these technologies create a coordinated translational framework that supports candidate prioritization, mechanistic toxicology, exposure prediction, and regulatory evidence generation.
Advanced In Vitro & Microphysiological Systems (MPS)
One of the most important developments in translational science is the rise of human-relevant microphysiological systems.
3D Cell Culture Systems
More accurately replicate tissue architecture and biological behavior.
Patient-Derived Organoids
Capture disease-specific characteristics using human-derived biology.
Organ-on-a-Chip Technologies
Simulate physiological responses within controlled microenvironments.
Complex Multicellular Co-Culture Models
Model interactions between multiple cell types and biological systems.
Unlike traditional two-dimensional assays, these systems better replicate tissue architecture, cellular signaling, mechanical stress responses, and human physiological microenvironments.
The FDA has emphasized the importance of biological relevance when selecting cell types, tissue architecture, and physiological functionality in NAM systems.
Human-relevant models allow researchers to observe drug responses under conditions that more closely resemble clinical biology.
